Pfizer

Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform… FiercePharma16:39
STAT Plus: Novo underwhelmed by drug it once fought Pfizer for STAT15:07
Which company could become the Chinese Pfizer? Here are analysts’ top picks South China Morning Post12:02
Pfizer (PFE) valuation check after recent share price pressure and rebuilding momentum Simply Wall St02:17
Here is what to know beyond why Pfizer Inc. (PFE) is a trending stock Zacks15:05
Pfizer (PFE) shares cross below 200 DMA Nasdaq21:24
Pfizer and Innovent Biologics agree on deal worth up to $10.5bn PMLiVE12:55

Latest News

Yesterday
SpaceX’s Healthcare Plays Forbes17:11 10-Jun-26
Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform… FiercePharma16:39 10-Jun-26
Pfizer CEO warns German investment at risk over drug pricing policies The Tribune, California13:19 10-Jun-26
In the last 7 days
Amneal and Pfizer GLP-1 Deal: New Growth Lever? Zacks18:20 9-Jun-26
Pfizer’s Hympavzi secures FDA expanded indications for haemophilia Hospital Management10:45 9-Jun-26
Pfizer's Monthly Obesity Drug Shows Promise NewsMax18:34 8-Jun-26
ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option BioPharma Dive17:10 8-Jun-26
Spotlight On: Herceptin® (trastuzumab) / Ogivri® (trastuzumab-dkst) / Herzuma® (trastuzumab-pkrb) / Ontruzant®… JD Supra16:51 8-Jun-26
Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi FiercePharma15:39 8-Jun-26
STAT Plus: Novo underwhelmed by drug it once fought Pfizer for STAT15:07 8-Jun-26
STAT Plus: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J… STAT14:38 8-Jun-26
Pfizer: FDA Expands Hympavzi Approval To Pediatric And Inhibitor Hemophilia Patients RTT News13:52 8-Jun-26
Pfizer Says FDA Approves Expanded Hympavzi Indication For Hemophilia A And B RTT News12:20 8-Jun-26
Facias sues Romanian Government over €600M Pfizer deal The Romania Journal12:19 8-Jun-26
US FDA approves Pfizer's bleeding disorder drug for children Rock Hill Herald12:07 8-Jun-26
U.S. FDA Approves Pfizer’s Hympavzi for the Treatment of Two Additional Hemophilia A or B… Business Wire (Press Release)11:47 8-Jun-26
Pfizer reports positive results from Phase IIb trial of berobenatide Clinical Trials Arena11:40 8-Jun-26
Pfizer-Partnered Obesity Drugmaker Eyes Deals Outside China Bloomberg Law22:15 7-Jun-26
Which company could become the Chinese Pfizer? Here are analysts’ top picks South China Morning Post12:02 7-Jun-26
3 Dividend Stocks to Buy Hand Over Fist in June The Motley Fool06:39 7-Jun-26
Can Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer. The Motley Fool18:46 6-Jun-26
Pfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems The Motley Fool17:46 6-Jun-26
Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial The Hindu Business Line14:28 6-Jun-26
STAT Plus: Detailed data show Pfizer’s monthly obesity drug continues to show potential STAT14:06 6-Jun-26
Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1… Business Wire (Press Release)14:05 6-Jun-26
Spotlight On: Lantus® / Lantus® SoloSTAR® (insulin glargine recombinant) / Basaglar® (insulin glargine) / Semglee®… JD Supra17:13 5-Jun-26
How the financial industry has curbed drug development Science Friday11:11 5-Jun-26
Pfizer signs licence agreement with Chai for AI drug discovery Pharmaceutical Business Review10:48 5-Jun-26
New US corporation tax regulations could put Ireland in Trump’s crosshairs The Irish Times05:05 5-Jun-26
Breckenridge announces launch of Tofacitinib Tablets, generic equivalent of Xeljanz® by Pfizer PR Newswire (Press Release)15:18 4-Jun-26
Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI Business Wire (Press Release)15:05 4-Jun-26
Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer? The Motley Fool07:37 4-Jun-26
Pfizer (PFE) Valuation Check After Recent Share Price Pressure And Rebuilding Momentum Simply Wall St02:17 4-Jun-26
In the last month
Bristol Myers vs. Pfizer: Which High‑Yield Dividend Stock Wins Now? The Motley Fool09:02 3-Jun-26
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 The Motley Fool07:51 3-Jun-26
Pfizer's Obesity and Oncology Pipeline Sets Up a Catalyst-Rich 2026 Zacks15:15 2-Jun-26
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock Zacks15:05 2-Jun-26
Pfizer (PFE) Shares Cross Below 200 DMA Nasdaq21:24 1-Jun-26
Pfizer Sues Alkem to Block Copies of Inlyta Kidney-Cancer Drug Bloomberg Law21:12 1-Jun-26
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool19:43 1-Jun-26
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire (Press Release)15:03 1-Jun-26
Pfizer and Innovent Biologics agree on deal worth up to $10.5bn PMLiVE12:55 1-Jun-26
Is Pfizer the Perfect Stock to Own with Kevin Warsh Heading the Fed? The Motley Fool10:01 1-Jun-26
AbbVie, Pfizer win broader reimbursement for oral JAK inhibitors in Korea Korea Biomedical Review03:11 1-Jun-26
ASCO 26: Three strong Pfizer Phase 3s, with Johanna Bendell pharmaphorum22:52 31-May-26
Is Pfizer Stock a "Value Trap" or a Generational Opportunity? The Motley Fool16:44 31-May-26
Pfizer’s Braftovi Regimen Nearly Doubles Median Progression-Free Survival in Metastatic… Business Wire (Press Release)13:05 31-May-26
How Is Pfizer's Stock Performance Compared to Other Healthcare Stocks? Barchart09:31 31-May-26
STAT Plus: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA STAT22:35 30-May-26
Why Wall Street Is Dead Wrong About This Popular Stock The Motley Fool20:42 30-May-26
Mailbag: A Follow-Up on Pfizer & Other Questions ETF Trends14:11 30-May-26
ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win FiercePharma13:04 30-May-26
Talzenna Plus Xtandi Improves Radiographic Progression-Free Survival by More Than 50% in… Business Wire (Press Release)13:03 30-May-26
STAT Plus: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer STAT22:35 29-May-26
STAT Plus: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval,… STAT22:35 29-May-26
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal BioWorld20:02 29-May-26
Pfizer, Innovent strike $10B cancer drug deal BioPharma Dive15:29 29-May-26
Seven-Year Analysis from Pfizer’s Lorbrena crown Trial Shows Longest Progression-Free Survival… Business Wire (Press Release)13:01 29-May-26
Pfizer and Innovent Biologics strike $10.5bn oncology deal spanning 12 cancer programmes Manufacturing Chemist11:55 29-May-26
Pfizer partners with Innovent for $10.5bn to advance ADC oncology medicines European Pharmaceutical Review11:20 29-May-26
Pfizer and Innovent Biologics sign $10.5bn cancer drug development deal Pharmaceutical Technology10:57 29-May-26
Pfizer Taps Early China Clinical Trials Via Innovent Deal Scrip Pharma Intelligence10:17 29-May-26
Innovent in line for $10.5bn in Pfizer cancer alliance pharmaphorum10:10 29-May-26
China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials South China Morning Post06:31 29-May-26
Pfizer inks up to $10.5 billion deal with China’s Innovent Biologics The Hindu Business Line03:14 29-May-26
China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn Nikkei Asian Review03:14 29-May-26
Innovent Biologics, Pfizer strike $10.5 billion cancer drug deal amid China biotech boom The Tribune, California01:36 29-May-26
Pfizer Inks Up to $10.5 Billion Deal With China’s Innovent (1) Bloomberg Law00:45 29-May-26
China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal The Tribune, California00:45 29-May-26
Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of … Business Wire (Press Release)00:07 29-May-26
Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of … PR Newswire (Press Release)00:00 29-May-26
Immune Thrombocytopenia Market Forecast Signals Steady Growth During the Forecast Period… PR Newswire (Press Release)15:05 28-May-26
BNT162b2 LP.8.1 early vaccine effectiveness against Covid-19 emergency department, urgent care, and outpatient visits Nature.com01:29 28-May-26
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare… Business Wire (Press Release)15:07 27-May-26
Pfizer Bets on New & Acquired Drugs to Offset Its LOE Pressure? Zacks14:56 27-May-26
ixlayer Appoints Helmut Osorio as General Manager to Accelerate Direct-to-Patient Growth for… PR Newswire (Press Release)12:04 27-May-26
China: the next Pfizer will be Chinese ING Think07:13 27-May-26
Report Claims Travis Kelce Earned More From Pfizer Deal Than His 2026 Chiefs Salary Gridiron Heroics19:24 26-May-26
This Healthcare Stock With 6%-Plus Yield: Is the Dividend Safe? The Motley Fool22:22 25-May-26
Why 1 Wall Street Analyst Thinks Pfizer (PFE) Stock Could Soar 38% The Motley Fool11:10 25-May-26
What's the Better Dividend Stock Today: AbbVie or Pfizer? The Motley Fool17:33 24-May-26
The Most Important Healthcare Stock You're Not Watching The Motley Fool22:40 22-May-26
Is Trending Stock Pfizer Inc. (PFE) a Buy Now? Zacks15:03 22-May-26
Scots lawyers fight for women disfigured by contraceptive jab as 40 come forward Glasgow Live11:40 22-May-26
Pfizer wins Singapore trademark dispute with Merck over vaccine brand The Straits Times09:07 22-May-26
Kazakhstan and Pfizer advance healthcare investment project Qazinform08:31 22-May-26
Number of Scottish women suing Pfizer for contraceptive jab tumours revealed Edinburgh Live07:12 22-May-26
Pfizer reports positive Phase II data for PF-07872412 in infants Clinical Trials Arena11:35 21-May-26
Pfizer takes 25-valent Prevnar follow-up into phase 3 pharmaphorum18:57 20-May-26
Pfizer Builds Oncology Growth Around Padcev and Pipeline Expansion Zacks16:48 20-May-26
Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer Business Wire (Press Release)14:04 20-May-26
Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Phase 2 Data RTT News12:32 20-May-26
Pfizer Advances Pneumonia Shot After Positive Study in Children Bloomberg Law10:24 20-May-26
Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase… Business Wire (Press Release)10:09 20-May-26
Pfizer, Moderna COVID vaccines 70% to 76% effective against severe illness in kids in 2022, data suggest Center for Infectious Disease Research and Policy19:27 19-May-26
Legal-Bay Pre Settlement Funding Provides Financial Support for Plaintiffs in Depo-Provera… PR Newswire (Press Release)11:03 19-May-26
Posts linking Covid jabs to hantavirus misuse Pfizer, WHO documents AFP Fact Check04:01 19-May-26
Pfizer’s Low Valuation Tests Whether Seagen Growth Can Offset the Patent Cliff Investing.com UK20:19 18-May-26
3 Deeply Undervalued Stocks You Can Buy for Less Than $100 Right Now The Motley Fool17:07 18-May-26
Woman left with bulging eye 'from 20 years of contraceptive jab' to sue Pfizer The Mirror14:40 18-May-26
Three Cork pharma giants win top honours at industry awards Cork Beo11:25 18-May-26
Scottish woman with bulging eye 'from 20 years of contraceptive jab' to sue Pfizer Edinburgh Live07:22 18-May-26
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus Antara News05:27 18-May-26
Scots woman left with bulging eye 'from 20 years of contraceptive jab' to sue Pfizer Daily Record04:41 18-May-26
Assessing Pfizer (PFE) Valuation After Recent Share Price Weakness And Oncology Growth Expectations Simply Wall St07:10 16-May-26
My Top 3 Healthcare Stocks for May 2026 The Motley Fool13:39 15-May-26
Fact File: Misleading claims about hantavirus shared online amid cruise ship outbreak CHEK News19:20 14-May-26
Pfizer Just Locked In Its Next 5 Years of Growth -- Here's How The Motley Fool16:07 14-May-26
PFE Stock Declines Post Q1 Beat: Book Profits or Stay Invested? Zacks15:01 14-May-26
The Zacks Analyst Blog Meta, Pfizer, Salesforce and Smith-Midland Zacks11:27 14-May-26
Pfizer receives EC approval for Hympavzi to treat haemophilia Hospital Management10:36 14-May-26
Pfizer Hemophilia Drug Win In Europe Adds Weight To Undervalued Thesis Simply Wall St03:04 14-May-26
Top Analyst Reports for Meta, Pfizer & Salesforce Zacks23:02 13-May-26
From oncology to obesity, Pfizer bets big on India for its next growth wave The Times of India20:19 13-May-26
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029? Zacks17:56 13-May-26

      
            
      
    view more headlines
   
      
      
      
10 Jun 17:11
   

Pfizer News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Pfizer news, covering the latest share price, vaccine news and more from the best online news publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Pfizer

Latest News

Pfizer News

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories